Persistence of Colonization of Intestinal Mucosa by a Probiotic Strain, Lactobacillus casei subsp. rhamnosus Lcr35, after Oral Consumption
Clicks: 265
ID: 114692
2003
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
265 views
36 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #62 of 85 articles by views in Journal of clinical microbiology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The colonization by the probiotic Lactobacillus casei subsp. rhamnosus Lcr35 of the gastrointestinal tracts of mice and humans was studied. The mice were orally given 109 CFU of Lcr35 either once or three times at 24-h intervals. A 16S ribosomal nucleic probe used in hybridization assays detected Lcr35 in the feces of mice for up to 3 days after the feeding, at a level of 108 to 109 CFU/g of feces. In the human assay, 12 healthy volunteers were enrolled in a randomized trial and ingested Lcr35 at a dosage of 108 or 1010 or 1012 CFU every day for 7 days. Then, after a 3-week posttreatment period, there was a second intake period similar to the first one. Analysis of fecal samples showed significant increases in the number of lactobacilli during the first intake period, whatever the dose given. The greatest increases were observed in subjects harboring the lowest indigenous population of Lcr35-like bacteria. During the 3-week posttreatment period, the number of CFU slightly decreased over time, and an increase, although not a statistically significant one, was observed during the second test period. These findings suggest that Lcr35 is able to survive within the gastrointestinal tract.
| Reference Key |
champs2003journalpersistence
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Christophe De Champs;Nathalie Maroncle;Damien Balestrino;Chantal Rich;Christiane Forestier;Christophe De Champs;Nathalie Maroncle;Damien Balestrino;Chantal Rich;Christiane Forestier; |
| Journal | Journal of clinical microbiology |
| Year | 2003 |
| DOI |
10.1128/JCM.41.3.1270-1273.2003
|
| URL | |
| Keywords |
Administration
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
Mice
RNA
animals
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
adult
female
male
adolescent
Ribosomal
16S / genetics
Inbred BALB C
intestinal mucosa / microbiology*
feces / microbiology
oral
probiotics / administration & dosage*
pmid:12624065
pmc150315
doi:10.1128/jcm.41.3.1270-1273.2003
christophe de champs
nathalie maroncle
christiane forestier
lactobacillus casei / physiology*
16s / analysis
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.